Diabetes, Vol 43, Issue 1 1-8, Copyright © 1994 by American Diabetes Association

ARTICLES

Activation of protein kinase C in glomerular cells in diabetes. Mechanisms and potential links to the pathogenesis of diabetic glomerulopathy

FR Derubertis and PA Craven
Department of Medicine, Veterans Affairs Medical Center, Pittsburgh, Pennsylvania.

Protein kinase C (PKC) is activated in rat renal glomerulus within a week of induction of experimental diabetes. Studies in isolated glomeruli and in cultured endothelial and mesangial cells have demonstrated that high ambient concentrations of glucose activate PKC and thus implicate hyperglycemia per se as a mediator of PKC activation in glomerular cells in diabetes. High glucose concentrations activate PKC by increasing cellular levels of diacylglycerol (DAG), the major endogenous modulator of this signalling system. In contrast to physiological extracellular stimuli of PKC that increase cellular DAG levels by receptor-mediated enhancement of membrane inositol phospholipid hydrolysis, in glomerular cells high concentrations of glucose increase DAG by de novo synthesis from glycolytic intermediates. Activation of PKC by glucose or other agonists increases the permeability of endothelial cells to albumin and stimulates matrix protein synthesis in mesangial cells; it thereby may be involved in the pathogenesis of both the functional and structural alterations of the glomerulus in diabetes. Recent studies in isolated glomeruli from diabetic rats have also implicated activation of PKC in suppression of nitric oxide (NO)-mediated increases in glomerular cGMP generation in response to cholinergic stimuli. In mesangial cells, cGMP suppresses PKC-mediated increases in matrix protein synthesis. Thus, impaired NO-mediated cGMP generation in glomeruli of diabetic individuals may amplify matrix protein synthesis in response to hyperglycemia and other stimuli of PKC. These and other observations suggest that activation of the PKC system by hyperglycemia may represent an important pathway by which glucotoxicity is transduced in susceptible cells in diabetes.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				Y. Qian, E. Feldman, S. Pennathur, M. Kretzler, and F. C. Brosius III From Fibrosis to Sclerosis: Mechanisms of Glomerulosclerosis in Diabetic Nephropathy Diabetes, June 1, 2008; 57(6): 1439 - 1445. [Full Text] [PDF]

				J. L. Burkey, K. M. Campanale, R. Barbuch, D. O'Bannon, J. Rash, C. Benson, and D. Small Disposition of [14C]Ruboxistaurin in Humans Drug Metab. Dispos., November 1, 2006; 34(11): 1909 - 1917. [Abstract] [Full Text] [PDF]

				M. B. Marrero, A. K. Banes-Berceli, D. M. Stern, and D. C. Eaton Role of the JAK/STAT signaling pathway in diabetic nephropathy Am J Physiol Renal Physiol, April 1, 2006; 290(4): F762 - F768. [Abstract] [Full Text] [PDF]

				H. Frecker, S. Munk, H. Wang, and C. Whiteside Mesangial cell-reduced Ca2+ signaling in high glucose is due to inactivation of phospholipase C-{beta}3 by protein kinase C Am J Physiol Renal Physiol, November 1, 2005; 289(5): F1078 - F1087. [Abstract] [Full Text] [PDF]

				V. Pech, J. D. Klein, S. D. Kozlowski, S. M. Wall, and J. M. Sands Vasopressin increases urea permeability in the initial IMCD from diabetic rats Am J Physiol Renal Physiol, September 1, 2005; 289(3): F531 - F535. [Abstract] [Full Text] [PDF]

				M. Brownlee The Pathobiology of Diabetic Complications: A Unifying Mechanism Diabetes, June 1, 2005; 54(6): 1615 - 1625. [Full Text] [PDF]

				S. K. Srivastava, K. V. Ramana, and A. Bhatnagar Role of Aldose Reductase and Oxidative Damage in Diabetes and the Consequent Potential for Therapeutic Options Endocr. Rev., May 1, 2005; 26(3): 380 - 392. [Abstract] [Full Text] [PDF]

				Y. Tan, B. Wang, J.-S. Keum, and A. A. Jaffa Mechanisms through which bradykinin promotes glomerular injury in diabetes Am J Physiol Renal Physiol, March 1, 2005; 288(3): F483 - F492. [Abstract] [Full Text] [PDF]

				S. Chu and H. G. Bohlen High concentration of glucose inhibits glomerular endothelial eNOS through a PKC mechanism Am J Physiol Renal Physiol, September 1, 2004; 287(3): F384 - F392. [Abstract] [Full Text] [PDF]

				C. Lindschau, P. Quass, J. Menne, F. Guler, A. Fiebeler, M. Leitges, F. C. Luft, and H. Haller Glucose-Induced TGF-{beta}1 and TGF-{beta} Receptor-1 Expression in Vascular Smooth Muscle Cells Is Mediated by Protein Kinase C-{alpha} Hypertension, September 1, 2003; 42(3): 335 - 341. [Abstract] [Full Text] [PDF]

				A. D. Hodgkinson, T. Bartlett, P. J. Oates, B. A. Millward, and A. G. Demaine The Response of Antioxidant Genes to Hyperglycemia Is Abnormal in Patients With Type 1 Diabetes and Diabetic Nephropathy Diabetes, March 1, 2003; 52(3): 846 - 851. [Abstract] [Full Text] [PDF]

				G. T. Lee, H. Ha, M. Jung, H. Li, S. W. Hong, B. S. Cha, H. Chul Lee, and a. Y. Dong Cho Delayed Treatment with Lithospermate B Attenuates Experimental Diabetic Renal Injury J. Am. Soc. Nephrol., March 1, 2003; 14(3): 709 - 720. [Abstract] [Full Text] [PDF]

				M. Guo, M. H. Wu, F. Korompai, and S. Y. Yuan Upregulation of PKC genes and isozymes in cardiovascular tissues during early stages of experimental diabetes Physiol Genomics, January 15, 2003; 12(2): 139 - 146. [Abstract] [Full Text] [PDF]

				N. Chaturvedi, C. G. Schalkwijk, H. Abrahamian, J. H. Fuller, and C. D.A. Stehouwer Circulating and Urinary Transforming Growth Factor {beta}1, Amadori Albumin, and Complications of Type 1 Diabetes: The EURODIAB Prospective Complications Study Diabetes Care, December 1, 2002; 25(12): 2320 - 2327. [Abstract] [Full Text] [PDF]

				X. Wang, S. Shaw, F. Amiri, D. C. Eaton, and M. B. Marrero Inhibition of the JAK/STAT Signaling Pathway Prevents the High Glucose-Induced Increase in TGF-{beta} and Fibronectin Synthesis in Mesangial Cells Diabetes, December 1, 2002; 51(12): 3505 - 3509. [Abstract] [Full Text] [PDF]

				C. I. Whiteside and J. A. Dlugosz Mesangial cell protein kinase C isozyme activation in the diabetic milieu Am J Physiol Renal Physiol, June 1, 2002; 282(6): F975 - F980. [Abstract] [Full Text] [PDF]

				C. W. Heilig, J. I. Kreisberg, S. Freytag, T. Murakami, Y. Ebina, L. Guo, K. Heilig, R. Loberg, X. Qu, Y. Jin, et al. Antisense GLUT-1 protects mesangial cells from glucose induction of GLUT-1 and fibronectin expression Am J Physiol Renal Physiol, April 1, 2001; 280(4): F657 - F666. [Abstract] [Full Text] [PDF]

				J. Christopher, V. Velarde, D. Zhang, D. Mayfield, R. K. Mayfield, and A. A. Jaffa Regulation of B2-kinin receptors by glucose in vascular smooth muscle cells Am J Physiol Heart Circ Physiol, April 1, 2001; 280(4): H1537 - H1546. [Abstract] [Full Text] [PDF]

				M. ISONO, M. C. I.-D. L. CRUZ, S. CHEN, S. W. HONG, and F. N. ZIYADEH Extracellular Signal-Regulated Kinase Mediates Stimulation of TGF-{beta}1 and Matrix by High Glucose in Mesangial Cells J. Am. Soc. Nephrol., December 1, 2000; 11(12): 2222 - 2230. [Abstract] [Full Text]

				C. WEIGERT, U. SAUER, K. BRODBECK, A. PFEIFFER, H. U. HÄRING, and E. D. SCHLEICHER AP-1 Proteins Mediate Hyperglycemia-Induced Activation of the Human TGF-{beta}1 Promoter in Mesangial Cells J. Am. Soc. Nephrol., November 1, 2000; 11(11): 2007 - 2016. [Abstract] [Full Text]

				L. R. James, I. G. Fantus, H. Goldberg, H. Ly, and J. W. Scholey Overexpression of GFAT activates PAI-1 promoter in mesangial cells Am J Physiol Renal Physiol, October 1, 2000; 279(4): F718 - F727. [Abstract] [Full Text] [PDF]

				S. Dhein, S. Hochreuther, C. a. d. Spring, K. Bollig, C. Hufnagel, and M. Raschack Long-Term Effects of the EndothelinA Receptor Antagonist LU 135252 and the Angiotensin-Converting Enzyme Inhibitor Trandolapril on Diabetic Angiopathy and Nephropathy in a Chronic Type I Diabetes Mellitus Rat Model J. Pharmacol. Exp. Ther., May 1, 2000; 293(2): 351 - 359. [Abstract] [Full Text]

				V. Scivittaro, M. B. Ganz, and M. F. Weiss AGEs induce oxidative stress and activate protein kinase C-beta II in neonatal mesangial cells Am J Physiol Renal Physiol, April 1, 2000; 278(4): F676 - F683. [Abstract] [Full Text] [PDF]

				D. KOYA, M. HANEDA, H. NAKAGAWA, K. ISSHIKI, H. SATO, S. MAEDA, T. SUGIMOTO, H. YASUDA, A. KASHIWAGI, D. K. WAYS, et al. Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC {beta} inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes FASEB J, March 1, 2000; 14(3): 439 - 447. [Abstract] [Full Text]

				M. B. Ganz, K. Hawkins, and R. F. Reilly High glucose induces the activity and expression of Na+/H+ exchange in glomerular mesangial cells Am J Physiol Renal Physiol, January 1, 2000; 278(1): F91 - F96. [Abstract] [Full Text] [PDF]

				M. P. Cohen, F. N. Ziyadeh, G. T. Lautenslager, J. A. Cohen, and C. W. Shearman Glycated albumin stimulation of PKC-beta activity is linked to increased collagen IV in mesangial cells Am J Physiol Renal Physiol, May 1, 1999; 276(5): F684 - F690. [Abstract] [Full Text] [PDF]

				Y. Song, M. Ailenberg, and M. Silverman Human munc13 Is a Diacylglycerol Receptor that Induces Apoptosis and May Contribute to Renal Cell Injury in Hyperglycemia Mol. Biol. Cell, May 1, 1999; 10(5): 1609 - 1619. [Abstract] [Full Text]

				A. C. Pflueger, H. Osswald, and F. G. Knox Adenosine-induced renal vasoconstriction in diabetes mellitus rats: role of nitric oxide Am J Physiol Renal Physiol, March 1, 1999; 276(3): F340 - F346. [Abstract] [Full Text] [PDF]

				M. Murphy, C. Godson, S. Cannon, S. Kato, H. S. Mackenzie, F. Martin, and H. R. Brady Suppression Subtractive Hybridization Identifies High Glucose Levels as a Stimulus for Expression of Connective Tissue Growth Factor and Other Genes in Human Mesangial Cells J. Biol. Chem., February 26, 1999; 274(9): 5830 - 5834. [Abstract] [Full Text] [PDF]

				P. Nelson, K Moissoglu, J Vargas, P. Klotman, and I. Gelman Involvement of the protein kinase C substrate, SSeCKS, in the actin-based stellate morphology of mesangial cells J. Cell Sci., January 2, 1999; 112(3): 361 - 370. [Abstract] [PDF]

				S. M. Haffner The Importance of Hyperglycemia in the Nonfasting State to the Development of Cardiovascular Disease Endocr. Rev., October 1, 1998; 19(5): 583 - 592. [Abstract] [Full Text]

				H. Hayakawa and L. Raij Nitric Oxide Synthase Activity and Renal Injury in Genetic Hypertension Hypertension, January 1, 1998; 31(1): 266 - 270. [Abstract] [Full Text] [PDF]

				K. Fukuda, S. Kawata, Y. Inui, S. Higashiyama, Y. Matsuda, T. Igura, S. Tamura, N. Taniguchi, and Y. Matsuzawa High Concentration of Glucose Increases Mitogenic Responsiveness to Heparin-Binding Epidermal Growth Factor–like Growth Factor in Rat Vascular Smooth Muscle Cells Arterioscler. Thromb. Vasc. Biol., October 1, 1997; 17(10): 1962 - 1968. [Abstract] [Full Text]

				A. Hempel, C. Maasch, U. Heintze, C. Lindschau, R. Dietz, F. C. Luft, and H. Haller High Glucose Concentrations Increase Endothelial Cell Permeability via Activation of Protein Kinase C{alpha} Circ. Res., September 19, 1997; 81(3): 363 - 371. [Abstract] [Full Text]

				A. G. Danielsen, F. Liu, Y. Hosomi, K. Shii, and R. A. Roth Activation of Protein Kinase Calpha Inhibits Signaling by Members of the Insulin Receptor Family J. Biol. Chem., September 15, 1995; 270(37): 21600 - 21605. [Abstract] [Full Text] [PDF]

				G. Bandyopadhyay, M. P. Sajan, Y. Kanoh, M. L. Standaert, T. R. Burke Jr., M. J. Quon, B. C. Reed, I. Dikic, L. E. Noel, C. B. Newgard, et al. Glucose Activates Mitogen-activated Protein Kinase (Extracellular Signal-regulated Kinase) through Proline-rich Tyrosine Kinase-2 and the Glut1 Glucose Transporter J. Biol. Chem., December 22, 2000; 275(52): 40817 - 40826. [Abstract] [Full Text] [PDF]

				H. Yoshikawa, Y. Kihara, M. Taguchi, T. Yamaguchi, H. Nakamura, and M. Otsuki Role of TGF-beta 1 in the development of pancreatic fibrosis in Otsuka Long-Evans Tokushima Fatty rats Am J Physiol Gastrointest Liver Physiol, March 1, 2002; 282(3): G549 - G558. [Abstract] [Full Text] [PDF]